Feasibility of Enteral Protein Supplementation in Critically Ill Children

JPEN J Parenter Enteral Nutr. 2018 Jan;42(1):61-70. doi: 10.1002/jpen.1018. Epub 2017 Dec 1.

Abstract

Background: We describe the protein type and concentration in standard enteral nutrition (EN) formulas and the effect of protein supplementation on the osmolality of standard formulas. We also aimed to examine factors associated with optimal protein delivery in critically ill children.

Methods: Protein content and other characteristics of pediatric EN formulas used worldwide were recorded. Factors associated with achievement of recommended protein delivery and tolerance of protein-supplemented formulas were recorded prospectively in a cohort of critically ill children. A range of protein supplement doses was added to 2 standard formulas and water, and the osmolality was recorded by cryoscopy in a bench experiment.

Results: We reviewed 125 formulas used in a multicenter study including sites from >13 countries. A majority of the EN formulas (73.6%) were polymeric, with a nonprotein calorie/nitrogen ratio of 182 ± 66 and protein content of 3.53 ± 2.00 g/100 mL. In the cohort of critically ill children, 28.5% achieved protein intake goal within 4 days, with no intolerance. In addition to optimal protein prescription (P < 0.001), protein supplementation (P = 0.018) and early EN initiation (P = 0.006) were associated with significantly higher odds of achieving goal protein intake. Formulas supplemented with up to 8 g/100 mL polymeric protein had osmolality <450 mOsm/kg.

Conclusions: The protein content of current pediatric formulas may be inadequate to meet the needs of critically ill children. Protein supplementation of formulas allows early achievement of goal and is likely to be safe.).

Keywords: critical illness; enteral nutrition; intensive care; osmolality; parenteral nutrition; protein; supplement; trial.

MeSH terms

  • Child
  • Child, Preschool
  • Critical Care / methods*
  • Critical Illness / therapy
  • Dietary Proteins / administration & dosage*
  • Dietary Supplements*
  • Enteral Nutrition / methods*
  • Feasibility Studies
  • Female
  • Humans
  • Infant
  • Length of Stay
  • Male

Substances

  • Dietary Proteins